子痫前期定义对高血压妊娠不良结局风险识别的影响:CHIPS试验分析
该研究为CHIPS随机对照试验的二次分析,纳入987例非严重非蛋白尿性妊娠高血压女性。结果显示,宽泛定义(蛋白尿或至少一项母体症状/体征/实验室异常)较限制性定义(新发蛋白尿)对不良妊娠结局的敏感性更高、特异性更低。结论认为宽泛定义能更好识别不良结局风险,但需在前瞻性研究中验证。
要点
- 宽泛子痫前期定义对不良结局的敏感性为62-79%,高于限制性定义的36-50%。
- 宽泛定义特异性为53-65%,低于限制性定义的72-82%。
- 加入死产或出生体重<第10百分位可提高宽泛定义的敏感性至74-87%。
核心结论
- 宽泛的子痫前期定义比限制性定义能更好地识别发生不良妊娠结局的女性。
研究设计与样本
- 研究为国际多中心随机对照试验CHIPS的二次分析。
- 纳入987例非严重非蛋白尿性妊娠高血压女性,其中979例有可用数据。
主要发现
- 280例(28.6%)进展为限制性定义子痫前期(新发蛋白尿),471例(48.1%)进展为宽泛定义子痫前期(蛋白尿或至少一项母体症状、体征或实验室异常)。
- 宽泛定义较限制性定义敏感性更高(62-79% vs 36-50%),特异性更低(53-65% vs 72-82%),诊断比值比和真阳性/假阳性比值相似或更高。
- 分层分析显示类似结果,加入可用的胎儿胎盘表现(死产或出生体重<第10百分位)后宽泛定义敏感性提高至74-87%。
临床怎么用
- 临床中采用宽泛子痫前期定义可能有助于识别更多有不良结局风险的女性,但需权衡监测和干预增加带来的成本及与患者价值观的一致性。
局限性
- 研究为二次分析,结果需在常规医疗环境的前瞻性研究中重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine the association between pre-eclampsia definition and pregnancy outcome. DESIGN: Secondary analysis of Control of Hypertension in Pregnancy Study (CHIPS) trial data. SETTING: International multicentre randomised controlled trial (RCT). POPULATION: In all, 987 women with non-severe non-proteinuric pregnancy hypertension. METHODS: We evaluated the association between pre-eclampsia definitions and adverse pregnancy outcomes, stratified by hypertension type and blood pressure control. MAIN OUTCOME MEASURES: Main CHIPS trial outcomes: primary (perinatal loss or high-level neonatal care for >48 hours), secondary (serious maternal complications), birthweight <10th centile, severe maternal hypertension, delivery at <34 or <37 weeks, and maternal hospitalisation before birth. RESULTS: Of 979/987 women with informative data, 280 (28.6%) progressed to pre-eclampsia defined restrictively by new proteinuria, and 471 (48.1%) to pre-eclampsia defined broadly as proteinuria or one/more maternal symptoms, signs or abnormal laboratory tests. The broad (versus restrictive) definition had significantly higher sensitivities (range 62-79% versus 36-50%), lower specificities (range 53-65% versus 72-82%), and similar or higher diagnostic odds ratios and 'true-positive' to 'false-positive' ratios. Stratified analyses showed similar results. Addition of available fetoplacental manifestations (stillbirth or birthweight <10th centile) to the broad pre-eclampsia definition improved sensitivity (74-87%). CONCLUSIONS: A broad (versus restrictive) pre-eclampsia definition better identifies women who develop adverse pregnancy outcomes. These findings should be replicated in a prospective study within routine healthcare to ensure that the anticipated increase in surveillance and intervention in a larger number of women with pre-eclampsia is associated with improved outcomes, reasonable costs and congruence with women's values. TWEETABLE ABSTRACT: A broad (versus restrictive) pre-eclampsia definition better identifies the risk of adverse pregnancy outcomes.
引用
- Magee LA, Singer J, Lee T, et al. The impact of pre-eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy - analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study). BJOG. 2021. PMID: 33230924. doi:10.1111/1471-0528.16602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。